Search in:

Expert Opinion on Biological Therapy Volume 9, 2009 - Issue 1

Submit an article Journal homepage

215

Views

CrossRef citations to date

Altmetric

Original Research

A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis

José M Ponseti Unit of Myasthenia Gravis, Autonomous University of Barcelona, Hospital General Universitari Vall d'Hebron, Department of Surgery, Passeig Vall d'Hebron 119 – 129, E-08035 Barcelona, Spain +34 93 2746000; +34 93 2746224; [email protected],[email protected]

, MD PhD FACS,

Norma Caritg Unit of Myasthenia Gravis, Autonomous University of Barcelona, Hospital General Universitari Vall d'Hebron, Department of Surgery, Passeig Vall d'Hebron 119 – 129, E-08035 Barcelona, Spain +34 93 2746000; +34 93 2746224; [email protected],[email protected]

Josep Gamez Autonomous University of Barcelona, Hospital General Universitari Vall d'Hebrón, Service of Neurology, Barcelona, Spain

Manuel López-Cano Unit of Myasthenia Gravis, Autonomous University of Barcelona, Hospital General Universitari Vall d'Hebron, Department of Surgery, Passeig Vall d'Hebron 119 – 129, E-08035 Barcelona, Spain +34 93 2746000; +34 93 2746224; [email protected],[email protected]

Ramón Vilallonga Unit of Myasthenia Gravis, Autonomous University of Barcelona, Hospital General Universitari Vall d'Hebron, Department of Surgery, Passeig Vall d'Hebron 119 – 129, E-08035 Barcelona, Spain +34 93 2746000; +34 93 2746224; [email protected],[email protected]

Manuel Armengol Unit of Myasthenia Gravis, Autonomous University of Barcelona, Hospital General Universitari Vall d'Hebron, Department of Surgery, Passeig Vall d'Hebron 119 – 129, E-08035 Barcelona, Spain +34 93 2746000; +34 93 2746224; [email protected],[email protected]

Pages 1-8 | Published online: 12 Nov 2008

Cite this article
https://doi.org/10.1517/14712590802588831

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Bibliography

Vincent A, Li Z, Hart A, et al. Seronegative myasthenia gravis. Evidence for plasma factor(s) interfering with acetylcholine receptor function. Ann NY Acad Sci 1993;681:529-38
PubMed Web of Science ®Google Scholar
Hoch W, Mc Conville J, Helms S, et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001;7:365-8
PubMed Web of Science ®Google Scholar
De Chiara TM, Bowen DC, Valenzuela DM, et al. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 1996;85:501-12
PubMed Web of Science ®Google Scholar
Plested CP, Tang T, Spreadbury I, et al. AChR phosphorylation and indirect inhibition of AChR function in seronegative MG. Neurology 2002;59:1682-8
PubMed Web of Science ®Google Scholar
Juel VC, Massey JM. Myasthenia gravis. Orphanet J Rare Dis 2007;2:44. Doi:10.1186/1750-1172-2-44
PubMed Web of Science ®Google Scholar
Leite MI, Ströbel P, Jones M, et al. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol 2005;57:444-8
PubMed Web of Science ®Google Scholar
Lavrnic D, Losen M, Vujic A, et al. The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry 2005;76:1099-102
PubMed Web of Science ®Google Scholar
Lauriola L, Ranelletti F, Maggiano N, et al. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 2005;64:563-8
Google Scholar
Jaretzki A 3rd, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards [Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America]. Neurology 2000;55:16-23
PubMed Web of Science ®Google Scholar
Ponseti JM, Gamez J, Vilallonga R, et al. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis. Eur J Cardiothorac Surg 2008;34:1062-7
PubMed Web of Science ®Google Scholar
Ponseti JM, Azem J, Fort JM, et al. Experience with starting tacrolimus postoperatively after extended thymectomy in patients with myasthenia gravis. Curr Med Res Opin 2006;22:885-95
PubMed Web of Science ®Google Scholar
Ponseti JM, Gamez J, Azem J, et al. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, con-controlled study. Curr Med Res Opin 2007;23:1269-78
PubMed Web of Science ®Google Scholar
Oosterhuis HJ. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry 1989;52:1121-7
PubMed Web of Science ®Google Scholar
Grob D, Brunner NG, Namba T. The natural course of myasthenia gravis and effect of therapeutic measures. Ann NY Acad Sci 1981;377:652-69
PubMed Web of Science ®Google Scholar
Evoli A, Tonali PA, Padua L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003;126:2304-11
PubMed Web of Science ®Google Scholar
Sanders DB, El-Salem K, Massey JM, et al. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 2003;60:1978-80
PubMed Web of Science ®Google Scholar
Kostera-Pruszczyk A, Kaminska A, Dutkiewicz M, et al. MuSK-positive myasthenia gravis is rare in the Polish population. Eur J Neurol 2008;15:720-4
PubMed Web of Science ®Google Scholar
Vincent A, Bowen J, Newsom-Davis J, McConville J. Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurol 2003;2:99-106
PubMed Web of Science ®Google Scholar
Illa I, Díaz-Manera JA, Juárez C, et al. Seronegative” myasthenia gravis and antiMuSK positive antibodies: description of Spanish series. [Article in Spanish]. Med Clin (Barc) 2005;125:100-2
PubMed Web of Science ®Google Scholar
Deymeer F, Gungor-Tuncer O, Yilmaz V, et al. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis. Neurology 2007;68:609-11
PubMed Web of Science ®Google Scholar
Padua L, Tonali P, Aprile I, et al. Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK- patients. Eur J Neurol 2006;13:273-6
PubMed Web of Science ®Google Scholar
Shibata-Hamaguchi A, Samuraki M, Furui E, et al. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis. Acta Neurol Scand 2007;116:406-8
PubMed Web of Science ®Google Scholar
Takahashi H, Kawaguchi N, Nemoto Y, Hattori T. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis. J Neurol Sci 2006;247:239-41
PubMed Web of Science ®Google Scholar
Hain B, Jordan K, Deschauer M, Zierz S. Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab. Muscle Nerve 2006;33:575-80
PubMed Web of Science ®Google Scholar
Ponseti JM, Gamez J, Azem J, et al. Tacrolimus for myasthenia gravis: a clinical study of 212 patients. Ann NY Acad Sci 2008;1132:254-63
PubMed Web of Science ®Google Scholar
Drachman DB, Jones RJ, Brodsky RA. Treatment of refractory myasthenia: “rebooting” with high-dose cyclophosphamide. Ann Neurol 2003;53:29-34
PubMed Web of Science ®Google Scholar
Yuan HK, Huang BS, Kung SY, Kao KP. The effectiveness of thymectomy on seronegative generalized myasthenia gravis: comparing with seropositive cases. Acta Neurol Scand 2007;115:181-4
PubMed Web of Science ®Google Scholar
Newsom-Davis J, Cutter G, Wolfe GI, et al. Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone. NY Acad Sci USA 2008;1132:344-7
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis

Bibliography

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis

Bibliography

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date